開示情報 > Signing of a new contract with StemRIM - Toward Investigator-initiated Clinical Study Implementation of S-005151 [Generic Name: Redasemtide] -

Signing of a new contract with StemRIM - Toward Investigator-initiated Clinical Study Implementation of S-005151 [Generic Name: Redasemtide] -

Signing of a new contract with StemRIM - Toward Investigator-initiated Clinical Study Implementation of S-005151 [Generic Name: Redasemtide] -

開示者 【45070】塩野義製薬株式会社
文書名 Signing of a new contract with StemRIM - Toward Investigator-initiated Clinical Study Implementation of S-005151 [Generic Name: Redasemtide] -  
PDF/XBRL [別ウインドウでPDFを開く]
開示日時 2020/06/30 チャネル/カテゴリ 東京証券取引所 /その他
ノート ログインするとIR文書にメモを入力して管理することができます
右上のログインメニューからログインしてください。


開示情報 > Signing of a new contract with StemRIM - Toward Investigator-initiated Clinical Study Implementation of S-005151 [Generic Name: Redasemtide] -